Anti-peptide reagent identifies a primary-structure-dependent, cross-reactive idiotype expressed on heavy and light chains from a murine monoclonal anti-cd4-Reference-Cited by-同舟云学术

Anti-peptide reagent identifies a primary-structure-dependent, cross-reactive idiotype expressed on heavy and light chains from a murine monoclonal anti-cd4

Published:1993-01 Issue:1 Volume:30 Page:9-17
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Attanasio Roberta,Kanda Patrick,Stunz Gregory W.,Buck David W.,Kennedy Ronald C.

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference23 articles.

1. Anti-idiotypic antibody response to monoclonal anti-CD4 preparations in non-human primate species;Attanasio;J. Immun.,1991

2. Structural characterization of a cross-reactive idiotype shared by monoclonal antibodies specific for the human CD4 molecule;Attanasio;J. biol. Chem.,1991

3. Idiotypic cascades associated with the CD4-HIV gp120 interaction: principles for idiotype-based vaccines;Attanasio;Int. Rev. Immun.,1990

4. Active site structure and antigen binding properties of idiotypically cross-reactive anti-fluorescein monoclonal antibodies;Bedzyk;J. biol. Chem.,1990

5. Synthetic peptides as antigens: pitfalls in conjugation methods;Briand;J. Immun. Meth.,1985

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-idiotypic antibodies as cancer vaccines: achievements and future improvements;Frontiers in Oncology;2012

2. Evidence of simian virus 40 exposure in a colony of captive baboons;Virology;2008-07

3. How Well Can an Idiotope Peptide Mimic Replace Its Parent Idiotype in a Synthetic Peptide Vaccine?;Pharmaceutical Research;2004-08

4. Idiotype Cascades Associated with the CD4-HIV Glycoprotein 120 Interaction: Immunization with Anti-Idiotypic Antibodies Induces Anti-Anti-Idiotypic Responses with Anti-CD4 Specificity and in Vitro Neutralizing Activity;AIDS Research and Human Retroviruses;2000-01

5. Bioactive CD4 ligands as pre- and/or postbinding inhibitors of HIV-1;Advances in Pharmacology;2000